Lifestyle Factors and Symptoms of Gastroesophageal Reflux Disease: A Cross-sectional Study
Abstract
Background and Objectives: Gastroesophageal Reflux Disease (GERD) is a condition characterized by heartburn and acid regurgitation without signs of oesophagal mucosal injury on one hand, and erosive oesophagitis and Barrett's oesophagus consequences like oesophagal cancer on the other. The aim of this study was to explore the involvement of different lifestyle-related factors in the aetiology of symptomatic GERD. Methods: In this cross-sectional study, 79 patients (28 men and 51 women) aged be-tween 20-68 years old were recruited randomly through a direct interview between January to October 2021, and they were prescribed Proton Pump Inhibitors. Prior to starting this study, the approvals had been granted by the ethics committee and oral consent was gained from the participants. A questionnaire was designed and consisted of demographic and clinical characteristics regarding GERD. Statistical analysis was done using SPSS version 25 for describing frequencies and percentages, followed by Chi-square and Fisher’s Exact tests as inferential statistical analysis for finding associations between variables. Results: Among the total of 79 patients with gastroesophageal reflux disease, the findings indicated that more than half of the study sample (58.2%) were overweight and obese (26.6% and 31.6% respectively), and the heavy smokers made the highest percentage among smokers (19%). There was a statistically significant association between gender and smoking and BMI among GERD patients…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 79 participants or records.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.